Device Trial Radar · NCT01611779
FAST as a Treatment for Obstructive Sleep Apnea
Last checked: Nov 20, 2026Latest source record: Feb 24, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Siesta Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 5, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to assess the feasibility and safety of tongue suspension using the Siesta Medical Encore Tongue Suspension System for the treatment of obstructive sleep apnea (OSA).
Conditions
- Obstructive Sleep Apnea
Interventions
Encore Tongue Suspension SystemDevice
The primary components of the Encore Tongue Suspension System consist of a suture passer, suspension line and bone screw.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Place the Implant and Stabilize the TongueTime frame: Up to 7 weeks after the procedure
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Atlanta Snoring and Sleep Disorders Institute
Atlanta, Georgia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.